Concourse Financial Group Securities, Inc. Rocket Pharmaceuticals, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding RCKT
# of Institutions
203Shares Held
92.8MCall Options Held
341KPut Options Held
107K-
Rtw Investments, LP New York, NY17.7MShares$440 Million7.65% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$228 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.93MShares$147 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$134 Million0.0% of portfolio
-
State Street Corp Boston, MA4.19MShares$104 Million0.01% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.88B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...